Single subcutaneous injection

DRUG2 trials

Sponsors

Peking Union Medical College Hospital

Conditions

Hypoparathyroidism

Phase 1

Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult Hypoparathyroidism

RecruitingNCT07530705

Peking Union Medical College HospitalHypoparathyroidism

Start: 2025-11-17End: 2026-06-30Target: 15Updated: 2026-04-15

Phase 2

A Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism

RecruitingNCT07540286

Peking Union Medical College HospitalHypoparathyroidism

Start: 2026-04-13End: 2030-07-30Target: 60Updated: 2026-05-18